Dompé is a 130+-year-old, family-owned biopharmaceutical company headquartered in Milan with 501–1,000 employees, focused on nerve growth factor (NGF) therapies and first-in-class treatments for eye, brain, and pain conditions. The hiring mix—dominated by sales (12), ops (8), and healthcare roles (5)—reflects an organization scaling commercial infrastructure and patient access programs; tech stack reveals manufacturing and ERP maturity (SAP S/4HANA, SCADA, IEC 61131-3 controls) paired with emerging data and AI tools (PyTorch, TensorFlow, Power BI), suggesting investment in both operational rigor and clinical/commercial analytics.
Notable leadership hires: Technical Director, Sales Director
Dompé develops and commercializes biologic therapies targeting underlying causes of neurological and ophthalmologic disease. The company operates as an integrated manufacturer and marketer, with internal R&D, manufacturing, and sales functions across Italy, the Balkans, and the United States. Current initiatives include QMS implementation for regional warehouses, digitalization of internal controls, enrollment platform deployment, and national sales strategy rollout—signaling expansion of commercial footprint and operational standardization. The pipeline spans ophthalmic, neurological, and pain indications, with at least one approved topical biologic already marketed.
Core ERP/productivity: SAP, Microsoft Office (Excel, PowerPoint, Outlook, Teams), Google Workspace. Manufacturing/controls: SAP S/4HANA, SCADA, PLC, HMI, Profibus, Ethernet/IP, IEC 61131-3. Analytics/data: Power BI, Power Query, DAX, Python, PyTorch, TensorFlow. Workflows: Asana, Trello, ServiceNow, Asana.
Current projects: QMS implementation for Albanian and Kosovar warehouses, digitalization of internal controls, digital enrollment platform deployment, national sales strategy, territory alignment, and patient access optimization initiatives. Also developing pricing frameworks and incentive compensation plans.
Other companies in the same industry, closest in size